The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...
ABC News' Linsey Davis speaks with White House National Security spokesman John Kirby on the latest in the cease-fire negotiations between Lebanon and Israel as tensions escalate in the region.
The US Food and Drug Administration has approved Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.
Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking ...
Babies conceived through assisted reproductive technology are more likely to be born with a major heart defect, new research ...
The US Food and Drug Administration has greenlit a new drug, marketed as Cobenfy, for oral use to treat schizophrenia in ...
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...